T. Rowe Price Health Care ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 34.58
成立日期: 11/06/2025
 
分析
市值分佈:
51.08%
大市值
4.39%
中市值
2.66%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:22) 總持有投資項目: 50  
0%
 
100%
     10大 (44.40%)
代號 名稱 佔比% 持有日期
ONCBeOne Medicines Ltd0.4030/06/2026
AZNAstraZeneca PLC0.3931/12/2025
WGSGeneDx Holdings Corp0.3630/06/2026
AVTXAvalo Therapeutics0.3630/06/2026
EIKNEikon Therapeutics0.3330/06/2026
FDMT4D Molecular Therapeutics0.3229/07/2026
STOKStoke Therapeutics0.3030/06/2026
OKUROnKure Therapeutics Inc0.3030/06/2026
ORKAOruka Therapeutics Inc0.3030/06/2026
STVNStevanato Group SpA0.2930/06/2026
CNTA--0.2730/05/2026
ZTSZOETIS0.2530/06/2026
IMCRImmunocore Holdings plc0.2530/04/2026
KARDKardigan Inc0.2430/07/2026
ALLOAllogene Therapeutics0.2230/06/2026
RAPPRapport Therapeutics Inc.0.2030/07/2026
MAZEMaze Therapeutics Inc0.2029/07/2026
IRONDisc Medicine0.2030/07/2026
ELVNEnliven Therapeutics0.2030/06/2026
SYRESpyre Therapeutics0.1929/07/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.